Cells use multiple feedback controls to regulate metabolism in response to nutrient and signaling 11 inputs. However, feedback creates the potential for unstable network responses. We examined how 12 concentrations of key metabolites and signaling pathways interact to maintain homeostasis in 13 proliferating human cells, using fluorescent reporters for AMPK activity, Akt activity, and cytosolic 14 NADH/NAD + redox. Across various conditions including metabolic (glycolytic or mitochondrial) inhibition 15 or cell proliferation, we observed distinct patterns of AMPK activity, including stable adaptation and 16
Introduction 31
A central function of cellular metabolic regulation is to ensure an adequate supply of metabolites 32 for bioenergetics and biosynthetic processes. To maintain metabolic homeostasis, cells utilize feedback 33 loops at multiple levels in an integrated metabolic-signaling network. For instance, glycolysis is 34 predominantly regulated by feedback control at the level of phosphofructokinase, which senses the 35 availability of ATP and the respiratory intermediate citrate. Additionally, in response to ATP depletion, 36 the energy-sensing kinase AMPK stimulates glucose uptake and suppresses energy-consuming 37 processes (Hardie, 2008) . The goal of these homeostatic pathways is to respond to bioenergetic stress 38 by increasing or decreasing the appropriate metabolic fluxes to return the cell to a state with stable and 39 sufficient levels of key metabolites. While bioenergetic stress can occur when any of a number of 40 metabolites becomes critically limited, we focus in this study on the key metabolite ATP because of its 41 broad importance as an energy source for cellular processes, and because AMPK activity can be used 42 as a reliable indicator of low ATP:AMP ratios within the cell. We therefore use the term bioenergetic 43 stress here to indicate a situation in which the concentration of available ATP is reduced, as indicated 44 by AMPK activation. 45
Bioenergetic stress can result from a loss of ATP production, such as when nutrients become 46 limited or metabolic pathways are inhibited by a pharmacological agent. Alternatively, ATP depletion 47 can also result from an increase in ATP usage, such as when anabolic processes are engaged during 48 cell growth. Because anabolic processes such as protein translation can use a large fraction (20-30%) 49 of cellular ATP (Buttgereit and Brand, 1995; Rolfe and Brown, 1997) , it is unsurprising that cellular 50 proliferation and metabolic regulation are tightly linked (Gatenby and Gillies, 2004; Wang et al., 1976) . 51
Growth factor (GF) stimulation activates the PI3K/Akt pathway, which plays a key role in proliferation by 52 stimulating both cell cycle progression and mTOR activity, leading to increased protein translation. 53
Simultaneously, Akt activity promotes glucose metabolism by stimulating the activity of hexokinase 54 (Roberts et al., 2013) and phosphofructokinase (Novellasdemunt et al., 2013) The balance of anabolic and catabolic processes is particularly important in epithelial tissues, as 59 they maintain the capacity to proliferate throughout adult life. Most cancers arise in epithelial cells 60 (Koppenol et al., 2011) and involve a loss of both signaling and metabolic regulation (Gwinn et al., 61 2008; Vander Heiden et al., 2009 ). The AMPK and Akt pathways play key roles in this balance, 62
intersecting through multiple crosstalk points and feedback loops to control both glucose metabolism 63 ( Fig.S1A ) and protein translation at the level of mTOR. In principle, an optimal feedback response to an 64 ATP-depleting perturbation would allow ATP levels to rapidly increase and stably restore ATP levels, 65
while unstable responses such as continuing fluctuations or oscillations could be deleterious for the cell. However, a system with multiple feedbacks requires unavoidable tradeoffs in efficiency and 67 robustness, and feedback increases the potential for instability (Chandra et al., 2011) . Experimentally, 68 such unstable metabolic responses have been observed in yeast (Dano et al., 1999; Ghosh and 69 Chance, 1964) and in specialized post-mitotic mammalian cell types (Chou et al., 1992; O'Rourke et al., 70 1994; Tornheim and Lowenstein, 1973; Yang et al., 2008) , confirming the potential for instability during 71 metabolic adaptation. However, in epithelial cells, little is known about the kinetic relationships between 72 signaling and metabolic activity that allow proliferation and other anabolic processes to proceed in step 73 with energy production. 74
To understand the kinetics of homeostasis, single-cell data are needed because of the potential 75 for metabolic state to vary even among genetically identical cells. Events that are asynchronous among 76 cells, and subpopulations with differential behaviors, are not apparent in the population mean due to 77 their tendency to "average out" (Purvis and Lahav, 2013) . Until recently, dynamics in metabolism could 
cells. 88
In this study, we established a panel of proliferative epithelial cells expressing multiple 89 fluorescent biosensors to enable detailed tracking of single-cell metabolic responses. We first used 90 pharmacologic compounds to induce bioenergetic stress and to establish the range of cellular 91 responses, finding that different forms of metabolic inhibition trigger strikingly different kinetics of 92 adaptation and revealing conditions under which stable adaptation fails. We then used this framework 93 to examine how metabolic adaptation functions in proliferating cells. We found that periods of 94 bioenergetic stress occur throughout the normal cell cycle, and we identified a prominent role for 95 low Akt activity, dephosphorylated FOXO3a translocates to the nucleus (Brunet et al., 1999; Tran et al., 139 2002) . To monitor Akt activity, we thus fused a red fluorescent protein mCherry to a truncated FOXO3a 140 gene in which transcriptional activity was abrogated to minimize any interference on endogenous gene 141 transcription, a strategy previously shown to specifically report Akt activity (Gross and Rotwein, 2016; 142 Maryu et al., 2016) . We refer to this construct as AKT-KTR; the Akt activity indicated by its cytosolic-to-143 nuclear fluorescence ratio is referred to as the 'Akt index' (Fig. 1I ). Upon insulin application following 144 GF deprivation, MCF10A-AKT-KTR cells showed an abrupt increase in Akt index ( Fig. 1K ), consistent 145 with the expected Akt stimulation. Conversely, pharmacologic treatment with the Akt inhibitor MK2206 146 induced an immediate decrease in Akt index (Figs. 1J, 1L), confirming that AKT-KTR could report Akt 147 activity dynamics in individual live cells. We generated dual-reporter cell lines expressing both AKT-148 KTR and AMPKAR2, or AKT-KTR and Peredox, allowing Akt activity and metabolic status to be 149 measured in the same cell. To track the relationship between proliferation and metabolic analysis, we 150 also constructed a cell line expressing both AMPKAR2 and a reporter of S/G2 phase, GMNN-mCherry 151 (Albeck et al., 2013; Sakaue-Sawano et al., 2008) . 152
We used our reporter cell lines to establish the relationship between metabolic, signaling, and 153 cell cycle parameters under different GF stimuli. Consistent with previous studies (Worster et al., 2012) 154 insulin treatment induced the strongest activation of Akt index, while EGF produced a more moderate 155 activation ( Fig. 2A) . Glucose uptake and NADH index were also highest in insulin-treated cells, 156 intermediate in EGF-treated cells, and lowest in the absence of GFs (Figs. 2B, 2C), while the average 157 AMPK index correlated inversely with Akt index (Fig. 2D ). Because EGF stimulated proliferation more 158 strongly than insulin ( Fig. S2A ), these metabolic parameters correlated poorly with proliferative rate. 159
Together, these results suggest that the increased rates of glucose uptake and metabolism stimulated 160 by Akt activity are the primary determinants of metabolic status under each GF. Accordingly, treatment 161 of insulin-cultured cells with an Akt or PI3K inhibitor decreased glucose uptake ( GF conditions, we lacked a framework to quantify and interpret these dynamics; we therefore turned to 166 defined metabolic perturbations as a tool to first establish basic homeostatic responses for single cells. 167
168

Fluctuating single-cell responses to metabolic challenges 169
To assess the range of individual cellular responses to specific bioenergetic challenges, we 170 exposed MCF10A-AMPKAR2 cells to a panel of metabolic inhibitors, including oligomycin (an inhibitor 171 of the mitochondrial F0/F1 ATPase), carbonyl cyanide m-chlorophenyl hydrazonesodium (CCCP, a 172 mitochondrial proton gradient uncoupler), and iodoacetate (IA; an alkylating agent that inhibits the 173 glycolytic enzyme GAPDH with minimal effects on other cellular thiols at <100 µM (Schmidt and Dringen, 2009)). As expected, each of these compounds rapidly raised the mean AMPK index in a 175 dose-dependent manner in cells cultured in growth medium, confirming that both glycolysis and 176 oxidative phosphorylation contribute to ATP production in proliferating MCF10A cells ( Fig. 3 , 177
Supplemental Movies 1-3). However, each inhibitor induced strikingly different kinetics at the single-cell 178 level. Notably, IA induced periodic oscillations of AMPK index, most evident at intermediate (5-10 µM) 179
IA concentrations in which oscillations were sustained for as many as 50 cycles over 20 hours ( Fig.  180   3A) . These fluctuations of AMPK activity were not synchronized among individual cells and thus not 181 apparent in the population average measurements. The asynchronous nature of these fluctuations 182 argued against imaging artifacts or environmental fluctuations, which would affect all cells 183 simultaneously. In contrast, oligomycin induced an immediate increase in AMPK index that peaked at 184 ~40 minutes but then fell, followed by a series of irregular pulses of AMPK activity ranging in duration 185 from 1-3 hours ( Fig. 3B ). 186
Because pulsatile AMPK activities were a common feature of the single-cell response to 187 multiple perturbations, we developed a "fluctuation score" to quantify the cumulative intensity of 188 fluctuations for each cell over time ( Fig. S3A and Methods section). Oligomycin and IA-treated cells 189 showed significantly increased fluctuation scores relative to untreated cells ( Fig. 3D ). However, other 190 perturbations resulted in different kinetic variations; for instance, at low and intermediate doses, CCCP 191 induced a rapid increase in AMPK index, with a magnitude comparable to the other perturbations, that 192 was maintained at a steady-state level for many hours with a low fluctuation score (Figs. 3C, 3D). 193
Higher doses of CCCP, which are known to inhibit respiration, exhibited similar effects as oligomycin. 194
We speculate that, at concentrations where CCCP acts only as an ionophore, a new stable steady state 195 is reached due to ATP consumption by the F0/F1 ATPase working in reverse and pumping protons to 196 maintain the mitochondrial electrochemical gradient; when proton flow is blocked by oligomycin (or 197 potentially by high doses of CCCP), AMPK kinetics are determined by other processes, which we 198 investigate below. Thus, bioenergetics and ATP levels exhibit distinct kinetics depending on the point of 199 perturbation; each inhibitor induces a different reconfiguration of the metabolic network and pattern of 200 feedback regulation. 201
Using AMPKAR2/GMNN reporter cells, we examined cell fates in response to each metabolic 202 inhibitor (Supplemental Movie 4). IA-treated cells rapidly ceased cell cycle progression ( Fig. S3B ) and 203 underwent lysis at varying times 12-24 hours following treatment. In oligomycin-treated cells, cell cycle 204 progression slowed but still led to normal mitoses, and viability was unaffected. While 1 µM CCCP 205 induced greater average AMPK index than oligomycin, neither cell cycle progression nor cell viability 206 were altered. Thus, cellular responses to metabolic perturbations do not correlate with overall 207 magnitude of bioenergetic stress. The observation that highly persistent dynamics are associated with 208 more extreme changes in cell fate suggests that the kinetics of stress response may play an important 209 role in determining cell fate.
Temporally coordinated oscillatory dynamics in bioenergetics and signaling upon inhibition of glycolysis 211
To understand why cells fail to reach stable adaptation under some conditions, we focused first 212 on the rapid oscillations triggered by IA treatment (Fig. 4A ). The average period of these oscillations 213 ranged from 18 minutes at 20-40 µM to 30 minutes at 5 µM ( Fig. 4B ). For IA at 10 µM or greater, the 214 percentage of cells displaying oscillations (defined as 5 or more successive pulses with a spacing of 1 215 hr or less) was >95%; this percentage fell to <60% at 5 µM IA, and no oscillation was detected at 216 concentrations of 2.5 µM or less ( an increase in AMPK index, and peaks of Akt and AMPK index remained shifted by 0.5 cycles 230 thereafter ( Fig. 4G ). Based on these relative phase shifts, we constructed a composite diagram of the 231 relationship between the three parameters ( Fig. 4H ). Thus, single-cell oscillations in PI3K/Akt activity, 232 AMPK activity, and glycolytic NADH production were temporally coordinated, suggesting that feedback 233 regulation tightly links these processes on the scale of minutes and leads to a persistent cycling of each 234
pathway. 235
We hypothesized that IA-induced oscillations in AMPK activity and NADH/NAD + ratio resulted 236 from oscillations in glycolytic flux, triggered by feedback-driven increases in the entry of glucose into 237 glycolysis upon GAPDH inhibition and flux reduction by IA. We therefore compared the fluctuation 238 scores for IA-treated cells in the presence of varying extracellular concentrations of glucose and 239 pyruvate. In the absence of glucose, IA treatment failed to induce oscillations in AMPK or NADH index 240 (Figs. S4B, S4C). The incidence of oscillations, and the corresponding fluctuation score, increased with 241 the extracellular glucose concentration in a dose-dependent manner, reaching a maximum at 4-5 mM, 242 while the average period and amplitude remained essentially constant. In contrast, pyruvate alone, 243 although capable of serving as an ATP source for MCF10A cells (Fig. S1B ) was unable to sustain IA-244 induced oscillations ( Fig. S4D ). Pyruvate also had no effect on IA-induced AMPK index oscillations in 245 the presence of glucose ( Fig. S4D ), although it rendered NADH index oscillations undetectable by lowering the resting NADH/NAD + ratio ( Fig. S4E ). Together, these observations indicate that pyruvate 247 does not fuel ATP production at a high enough rate to impact the rapid oscillatory changes during IA 248 treatment. The data support the conclusion that these rapid oscillatory dynamics originate from 249 changes in flux in glycolysis, with downstream metabolic processes playing little role. 250
Oscillations often arise in feedback systems in which there is a delay between induction of 251 feedback and recovery of the feedback-controlled variables (Glass et al., 1988) . The co-oscillation of 252
Akt activity along with AMPK and NADH index suggests the involvement of a complex feedback 253 structure involving PI3K/Akt, AMPK, and also mTOR ( Consistent with this idea, multiple inhibitors of mTOR and PI3K activity suppressed IA-induced NADH 255 oscillations ( Fig. 4I ). Suppression was most potent with BEZ-235, which inhibits PI3K, mTORC1, and 256 mTORC2 activity, and strong but somewhat less potent with Torin1, which inhibits both mTORC1 and 257 mTORC2. Both rapamycin, which inhibits mTORC1 alone, and BKM-120, which inhibits only PI3K, had 258 more limited but still significant ability to block oscillations. Withdrawal of insulin from the growth 259 medium, which simultaneously reduces Akt and mTOR activity and glucose uptake ( with no subsequent adaptation, followed by cell death in 100% of cells within 12 hours. In 17.5 mM 276 glucose (the baseline concentration for MCF10A media), oligomycin induced a rapid initial pulse of 277 AMPK activity and subsequent adaptation, with >75% of cells returning to baseline AMPK index within 278 2 hours. Following this adaptation, cells displayed regular pulsatile dynamics in AMPK index, with an 279 average period of ~2.5 hours; the first two pulses of AMPK index were highly synchronous among cells, 280 followed by gradual de-synchronization. As with the initial pulse, each burst of AMPK activity lasted 2-4 281 hours, suggesting that continuing oligomycin treatment induced ongoing bioenergetic challenges, which were nevertheless overcome by cells maintained at 17.5 mM glucose. At glucose concentrations of 3.4 283 mM and 1.7 mM, cells were unable to achieve full adaptation, with <25% and <10% of cells returning to 284 baseline within 2 hours, and subsequent pulses in AMPK index were relatively dampened and 285 prolonged. Thus, under high glucose levels, recovery of ATP levels occurs quickly and completely, but 286
gives rise to recurring pulses of AMPK activity, suggesting that changes in the rate of ATP production 287 by glucose metabolism via glycolysis generate these pulses. 288
We next examined how GF regulation of glucose metabolism impacts these dynamics ( Fig. 5B) . 289
In the presence of glutamine, treatment with insulin strongly suppressed oligomycin-induced pulses in 290 AMPKAR index, relative to non-GF treated cells. While EGF moderately increased the strength of 291 pulses, co-treatment with both EGF and insulin led to suppression of pulses (Figs. 5B, 5C). This 292 suppression was negated by co-treatment with Akt inhibitor, which strongly enhanced oligomycin-293 induced AMPKAR pulses ( Fig. S5C ). Similarly, in the presence of insulin, moderate inhibition of 294 glycolysis with a dose of IA too low to independently stimulate oscillations resulted in amplification of 295 oligomycin-induced AMPK pulses ( Fig. S5D ). Thus, the enhancement of glucose metabolism by insulin-296 mediated signaling is capable of attenuating recurrent ATP shortages following adaptation to 297
oligomycin. 298
The pronounced and relatively regular nature of oligomycin-induced AMPK index oscillations in 299 the presence of glucose alone ( Fig. 5A) , as compared to the more irregular pulses seen in complete 300 growth medium ( Fig. 3A ), suggested that glutamine or pyruvate, which are present in complete 301 medium, may also influence oligomycin-stimulated oscillations. While pyruvate had no effect on the 302 kinetics of oligomycin response, the amplitude and regularity of pulsing were strongly attenuated when 303 glutamine was present (Figs. S5E, S5F). When we performed the same experiment in the presence of 304 different GF stimuli, we found that glutamine was required for the suppression of oscillations by insulin 305 (Figs. 5D, 5E). However, regardless of the presence of insulin, cells cultured in the presence of 306 glutamine without glucose failed to recover their AMPK index and died within 12 hours ( Fig. S5F) , 307
suggesting that glutamine may play a role in supporting glucose metabolism, but cannot alone provide 308 sufficient ATP in the absence of oxidative phosphorylation. 309
Altogether, these data suggest a model whereby, in the presence of high glucose, feedback 310 regulation of glucose metabolism via glycolysis upon oligomycin treatment leads to recovery of ATP 311 levels ( Fig. S5G ). However, this sharp increase in rate triggers negative feedback regulation of 312 glycolysis, causing ATP levels to fall again ( Fig. S5G, top ). Insulin and glutamine counter these 313 negative feedbacks, allowing glycolysis to continue at a high rate and thereby maintain high ATP levels 314
( Fig. S5G, bottom) . In contrast, in the presence of low glucose, oligomycin cannot stimulate a large 315 enough increase in glycolysis to rapidly restore ATP levels, and negative feedback is not triggered, 316
resulting in ATP levels that remain at lower, but stable, levels ( Fig. S5G, middle) . 317
Akt-stimulated glucose uptake is required for bioenergetic stability in proliferation 319
Finally, we returned to the question of how GF stimulation and proliferation impact bioenergetic 320 stability even in the absence of overt metabolic perturbations. We quantified the AMPK index fluctuation 321 scores for GF-stimulated MCF-10A cells; we found that while AMPK index fluctuations under these 322 conditions were less pronounced than in IA-or oligomycin-stressed cells, significantly more fluctuations 323 occurred in non-GF-or EGF-treated cells relative to cells treated with insulin or a combination of insulin 324 and EGF (Figs. 6A, 6B). To understand the basis for these fluctuations, we first used the Geminin cell 325 cycle reporter to examine cell cycle-dependent differences in AMPK index. In EGF-stimulated cells in 326 which AMPK fluctuations were most prominent, we compared the AMPK fluctuation scores between 327 G0/G1 and S/G2/M phases of the cell cycle ( Fig. 6C ) and found that AMPK activity was significantly 328 more pulsatile in G0/G1 cells. However, this moderate difference between cell cycle phases does not 329 explain the overall effect of GFs on AMPK kinetics: compared to EGF-treated cells, insulin-treated cells 330 are more likely to be in G0/G1 but have a lower probability of AMPK index fluctuations. We therefore 331 next investigated the involvement of Akt by simultaneously monitoring both Akt and AMPK in dual 332 reporter MCF10A-AMPKAR2/AKT-KTR cells. Analysis of fluctuations in both reporters on a cell-by-cell 333 basis revealed a high frequency of inverse events, with a pulse in AMPK index mirrored by a decrease 334 in Akt index ( Fig. 6D ). Cross-correlation analysis indicated that such inverse events were highly 335 overrepresented in the population relative to their expected occurrences at random ( Fig. 6E) , 336
suggesting that AMPK fluctuations may result at least in part from rises and falls in Akt activity and the 337 associated rate of glucose uptake. 338
We further tested the role of the PI3K/Akt pathway in bioenergetic stress using pharmacological 339 inhibitors of this pathway. In cells growing in the presence of either insulin alone or a combination of 340 insulin and EGF, treatment with either PI3K inhibitor (BKM120) or Akt inhibitor (MK-2206) increased the 341 understanding these metabolic dynamics, rather than simply average or baseline concentrations, will be 358 crucial in developing an integrated model for the control of cellular metabolism and growth. 359
Feedbacks in metabolic control enable the cell to maintain adequate levels of key metabolites 360 under non-ideal circumstances. Because ATP plays a central role in providing energy for many 361 essential cellular processes, even short lapses in availability can potentially compromise cellular 362 function and viability; it is likely that evolution has selected for feedback kinetics that rapidly reverse any 363 decrease in ATP to prevent levels from falling dangerously low. Consistent with this idea, we find that 364 cells provided with different fuel sources (glucose, glutamine, and pyruvate) are able to adapt and 365 maintain steady levels of AMPK activity with few fluctuations, albeit at different set points that depend 366 on the fuel source (Figs. S1B, S1C). However, optimization for such rapid and efficient adaptation 367 comes with the potential that for certain conditions stable adaptation cannot be achieved, and unstable 368 circumstances, including mutations of metabolic enzyme genes or pharmacological or toxic compounds 378 that impair metabolic function, and may be important for the understanding of tissue function in these 379 cases. In the epithelial cells examined here, metabolic oscillations coincide with decreases in cellular 380 function ranging from slowed proliferation to cell death, suggesting that the oscillations represent a 381 deleterious side effect of feedback control. Nevertheless, it has also been proposed that sustained 382 glycolytic oscillations could play an important role in fine-tuning certain cellular functions, such as 383 insulin secretion in pancreatic beta cells (Goodner et al., 1977) . 384 385
Glycolysis and insulin signaling in the control of metabolic stability 386
Our results point to a central role for glycolysis in mediating metabolic stability. Despite its 387 relative inefficiency in ATP yield per molecule of glucose, glycolysis can, at least under certain 388 conditions, produce ATP at a faster rate than oxidative phosphorylation if sufficient glucose is available; 389 this ability is best documented in muscle cells during anaerobic activity but could conceivably extend to other situations such as hypoxic cells within a tumor (Liberti and Locasale, 2016) . Our results also 391 implicate insulin and the PI3K/Akt pathways as controlling factors in bioenergetic stability, consistent 392 with their stimulatory effect on glucose uptake and glycolytic flux. The data presented here suggest that 393 the capacity for rapid ATP production by glycolysis can play both positive and negative roles in 394 bioenergetic stability. For example, insulin enhances the occurrence of IA-induced oscillations (Fig. 4I) , 395 but has a suppressive role for oligomycin-induced oscillations (Fig. 5C ). In our oscillation models (Figs. 396 S4G, S4H, and S5G), this difference is consistent with the configuration of the network in each case. In 397 the case of IA, where a bottleneck is imposed between upper and lower glycolysis, higher glucose input 398 stimulated by insulin would increase both the maximum rate for ATP production and the strength of 399 negative feedback, but flux from upper to lower glycolysis would remain limited by the inhibitor, leading 400 to stronger oscillations. In the case of oligomycin, increasing the flux through glycolysis to its maximum 401 rate enables the pathway to produce sufficient ATP in the absence of oxidative phosphorylation, 402 preventing negative feedback from AMPK to initiate oscillations. Thus, while glycolysis is the preferred 403 route to quickly restore ATP levels when they fall, the resulting rapid changes in ATP and other 404 metabolites may also facilitate oscillatory behavior, as slower regulatory processes attempt to catch up 405 to the increased glycolytic flux. We speculate that in the epithelial cells examined here, a core glycolytic oscillator becomes entrained 414 through feedback connections to these additional regulatory pathways that are central to growth and 415 homeostasis in this cell type. Our data also suggest that metabolic oscillations may be a wider 416 phenomenon than previously thought, as we demonstrate their occurrence in cells not typically 417 considered highly metabolically active, and also find that they may occur with heterogeneous phasing 418 that makes oscillations impossible to detect without single cell methods. The tools developed here will 419 be of use in detecting and analyzing similar oscillations in other cell types and conditions. 420 421
Implications of energetic stability in GF signaling, carcinogenesis, and pharmacotherapy 422
Given that over 90% of human tumors arise in epithelial tissue and that abnormal cell 423 proliferation underlies carcinogenesis, understanding metabolic requirements for proliferating epithelial 424 cells can have profound implications in oncology research. Our findings offer a potential explanation for 425 the metabolic advantage conferred by aerobic glycolysis in tumors and proliferating cells. Existing hypotheses for why aerobic glycolysis is common in proliferating cells include rapid ATP generation by 427 glycolysis (though less efficient than oxidative phosphorylation), as well as increased fluxes to glycolytic 428 intermediates for biosynthesis (Sullivan et al., 2015) . We find that in the presence of EGF, where ATP 429 and NADH are low but proliferative rate is high, cells display increased bioenergetic instability and 430 sensitivity to inhibition of oxidative respiration, which can be reversed by insulin-mediated activation of 431
Akt. In the context of tumor microenvironments with fluctuating nutrient and oxygen supply, such 432 instability is likely deleterious and may create selective pressure for genetic alterations to enhance 433 glycolysis, such as activating mutations in the PI3K/Akt pathway, which are among the most frequent 434 mutations across all cancer types. Investigating the effects of oncogenic mutations on metabolic 435 stability may thus be important in developing therapies that target the altered metabolism of tumor cells. expression; all data reported in this study reflect representative behaviors that were highly consistent 470 across all clones of each reporter (a minimum of three clones in each case). 471
For microscopy, we used a custom formulation with minimal background fluorescence, termed 472 imaging-modified growth medium (iGM), which consists of DMEM/F12 lacking riboflavin, folic acid, and 473 phenol red (Life Technologies). Lacking these three components had no effect on reporter kinetics, as 474
indicated by experiments performed in normal growth medium lacking only phenol red (not shown), but 475 allowed for more accurate quantification of reporter signals. iGM contained all supplements used in 476 MCF10A culture medium (above), but with horse serum replaced by 0.1% (w/v) bovine serum albumin. 477
In order to lower the amounts of extracellular pyruvate and facilitate measurements of cytosolic NADH-478 NAD + redox (Hung et al., 2014) in some experiments, we used an alternate imaging medium 479 formulation, termed iGM2, which consists of 95% DMEM (Life Technologies 31053) and 5% 480 DMEM/F12 (Life Technologies 11039), supplemented with 0.3% bovine serum albumin, EGF, insulin, 481 hydrocortisone, cholera toxin, and pen-strep as above. For Peredox calibration using lactate and 482 pyruvate, DMEM (31053) with indicated lactate and pyruvate concentrations were made; cells were 483 washed once to two times with the media prior to imaging. For GF titration, cells were placed in 484 EGF/insulin-deficient medium for 2 days prior to imaging with appropriate concentrations of EGF and 485 insulin. For glucose titration, DMEM (Life Technologies A14430) with indicated glucose concentrations 486 were prepared (with residual F12 supplementation of 0.8% in media with 0.03 mM to 23 mM glucose); 487 cells were washed two to three times with the respective media prior to imaging. A. Mean Akt index, measured by Akt-KTR, following stimulation with EGF or insulin. Prior to imaging, 785 cells were placed in medium lacking EGF or insulin. GFs were added at time 0. N=4, combined. 786 B. Mean NADH index, measured by Peredox, following stimulation with EGF or insulin. Prior to 787 imaging, cells were placed in medium lacking EGF or insulin. GFs were added at time 0. N=4, 788
combined. 789 C. Glucose uptake from culture medium by MCF10A cells. Glucose depletion from the medium was 790 assayed immediately following a 2 hour period during which the cells were exposed to the indicated B. Decrease in glucose uptake upon Pi3K/Akt inhibition. Glucose depletion from the medium was 899 assayed immediately following a 2 hour period during which the cells were exposed to the indicated 900 conditions. All measurements were made in the presence of EGF and Insulin, and measurements are 901 normalized to the DMSO condition. an increase in the availability of glucose and UG metabolites; the decrease in Akt activity during this 958 phase may be due to relief of mTOR inhibition by flux through HK (connection #4 in Fig. S1A ), leading 959 to negative feedback inhibition of Akt (connection #6 in Fig. S1A ). (4) High levels of UG increase the 960 levels of LG metabolites, overcoming the partial inhibition of flux imposed by IA; ATP levels rise, and 961 net feedback switches from positive to negative. (5) Reduction of glycolytic flux leads to a relaxation of 962 the levels of glycolytic metabolites; negative feedback deactivates. In a normal (non-IA-inhibited) state, 963 this level of flux would be sufficient to maintain ATP levels, and the cell would return to a normal state 964 (0). However, since IA remains present, flux from UG to LG is again inhibited and the cell returns to 965 state (1), beginning a new repetition of the cycle. 
